Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ: XERS · Real-Time Price · USD

6.09

-0.03 (-0.49%)

At close: Apr 28, 2026, 4:00 PM EDT

6.19

+0.10 (1.64%)

After-hours: Apr 28, 2026, 7:41 PM EDT

Xeris Biopharma Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	291.85	203.07	163.91	110.25	49.59
Revenue Growth (YoY)	43.72%	23.89%	48.68%	122.32%	142.67%
Cost of Revenue	42.57	36.83	28.65	22.63	13.32
Gross Profit	249.28	166.24	135.27	87.61	36.27
Selling, General & Admin	182.37	163.48	146.1	137.75	125.72
Depreciation & Amortization Expenses	10.84	10.84	10.84	10.84	0.55
Research & Development	31.17	25.56	22.34	20.97	25.16
Total Operating Expenses	224.38	199.88	179.28	169.55	151.43
Operating Income	24.9	-33.65	-44.01	-81.94	-115.16
Interest Income	4.74	5.32	4.75	2.58	0.31
Interest Expense	-29.08	-30.49	-26.61	-14.1	-7.18
Other Non-Operating Income (Expense)	-	1.71	2.36	-2.62	-0.7
Total Non-Operating Income (Expense)	-24.34	-23.46	-19.49	-14.14	-7.57
Pretax Income	0.55	-57.1	-63.5	-96.08	-122.73
Provision for Income Taxes	-	-2.27	-1.25	-1.42	-
Net Income	0.55	-54.84	-62.26	-94.66	-122.73
Net Income to Common	0.55	-54.84	-62.26	-94.66	-122.73
Shares Outstanding (Basic)	160	147	138	136	79
Shares Outstanding (Diluted)	173	147	138	136	79
Shares Change (YoY)	17.69%	6.61%	1.51%	71.62%	85.32%
EPS (Basic)	0.00	-0.37	-0.45	-0.70	-1.55
EPS (Diluted)	0.00	-0.37	-0.45	-0.70	-1.55
Shares Outstanding	166.22	149.43	138.13	136.27	124.87
Free Cash Flow	27.93	-37.85	-49.29	-103.42	-96.62
Free Cash Flow Per Share	0.16	-0.26	-0.36	-0.76	-1.22
Gross Margin	85.41%	81.86%	82.52%	79.47%	73.14%
Operating Margin	8.53%	-16.57%	-26.85%	-74.32%	-232.22%
Profit Margin	0.19%	-27.00%	-37.98%	-85.86%	-247.48%
FCF Margin	9.57%	-18.64%	-30.07%	-93.80%	-194.84%
EBITDA	37.05	-21.58	-31.68	-69.7	-113.28
EBITDA Margin	12.70%	-10.62%	-19.33%	-63.22%	-228.43%
EBIT	24.9	-33.65	-44.01	-81.94	-115.16
EBIT Margin	8.53%	-16.57%	-26.85%	-74.32%	-232.22%
Effective Tax Rate	0.00%	3.97%	1.97%	1.48%	0.00%

Updated Mar 2, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q